Medical Cannabis Decree in France: Legal Framework and Origin of the Scheme
đĄ Update Note: What is the status of medical cannabis in France?
This article traces the historical context of the publication of the foundational decree for the experiment. For a complete and up-to-date overview of the regulations, a review of indications, and the steps for generalization, discover our updated report: Medical Cannabis in France: Experimentation, ANSM, and Status.
The publication of the official decree from the Ministry of Solidarity and Health regarding medical cannabis marked a decisive step for specialized medicine in France. This text established the first legal rules to frame the implementation of a national experimental protocol.
1. The Foundational Decree: Objectives and Conditions of Application
Anticipated by many associations and health professionals, this decree formalized the organization and general supervision of the system:
- Administrative supervision: framing of the experiment by the Directorate General of Health (DGS) and the ANSM.
- Patient inclusion: targeting a panel of 3,000 patients with therapeutic impasses, suffering from specific pathologies (refractory neuropathic pain, severe epilepsies, palliative care, oncology, or painful muscle spasticity).
- Supervised care pathway: commitment to the principle of volunteering for doctors and pharmacists, conditioned by mandatory prior training.
- Treatment modalities: free provision of health products for included patients throughout the evaluation phase.
2. Parliamentary Debates and the Construction of a Sector
During the drafting of the text, parliamentary amendments raised the question of developing a French agricultural and industrial sector from the trial phase, as well as the remuneration of suppliers. The government then chose to prioritize the launch schedule, relying on international actors already possessing pharmaceutical production standards (EU-GMP).
This initial framework paved the way for the progressive structuring of the care pathway, from the training of practitioners to securing the distribution chain in pharmacies.
3. Medical Cannabis vs. CBD Wellness: A Reminder of the Differences
A strict distinction should be made between medical cannabis treatments and over-the-counter wellness hemp extracts:
- Medical Cannabis: This includes prescription medications containing THC and CBD, prescribed exclusively in hospitals and dispensed in pharmacies for defined clinical indications. To better understand the action of cannabinoids on the body, you can discover how the endocannabinoid system works.
- CBD Wellness: These are products derived from authorized hemp varieties with a THC content strictly below 0.3%. They are not intended to treat a disease and are used to support a balanced lifestyle. To preserve the quality of your habits, it is essential to avoid synthetic molecules.
To understand the natural balance of the plant, do not hesitate to understand how the entourage effect works. If you wish to explore the variety of natural extracts, you can discover our organic CBD flowers or explore our French CBD resins.
Reminder: wellness CBD products are not medicines and cannot in any way replace medical treatment.